Source: Oral Diseases. Unidade: FO
Subjects: MIELOMA MÚLTIPLO, LINFOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMASI, A. P. D et al. Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Oral Diseases, v. no 2008, n. 8, p. 741-746, 2008Tradução . . Disponível em: https://doi.org/10.1111/j.1601-0825.2008.01455.x. Acesso em: 14 jun. 2024.APA
Demasi, A. P. D., Magalhães, M. H. C. G., Furuse, C., Araújo, N. S. de, Junqueira, J. L. C., & Araújo, V. C. de. (2008). Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Oral Diseases, no 2008( 8), 741-746. doi:10.1111/j.1601-0825.2008.01455.xNLM
Demasi APD, Magalhães MHCG, Furuse C, Araújo NS de, Junqueira JLC, Araújo VC de. Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas [Internet]. Oral Diseases. 2008 ; no 2008( 8): 741-746.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1111/j.1601-0825.2008.01455.xVancouver
Demasi APD, Magalhães MHCG, Furuse C, Araújo NS de, Junqueira JLC, Araújo VC de. Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas [Internet]. Oral Diseases. 2008 ; no 2008( 8): 741-746.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1111/j.1601-0825.2008.01455.x
